Petros Pharmaceuticals Inc

NASDAQ:PTPI USA Drug Manufacturers - Specialty & Generic
Market Cap
$101.47K
Market Cap Rank
#41083 Global
#13347 in USA
Share Price
$0.05
Change (1 day)
-28.18%
52-Week Range
$0.01 - $0.30
All Time High
$46.80
About

Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.

Petros Pharmaceuticals Inc (PTPI) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of March 2025: 0.156x

Based on the latest financial reports, Petros Pharmaceuticals Inc (PTPI) has a cash flow conversion efficiency ratio of 0.156x as of March 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.49 Million) by net assets ($-9.58 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Petros Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how Petros Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Petros Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Petros Pharmaceuticals Inc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Petros Pharmaceuticals Inc (2018–2024)

The table below shows the annual cash flow conversion efficiency of Petros Pharmaceuticals Inc from 2018 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $-7.47 Million $-2.60 Million 0.349x +157.04%
2023-12-31 $12.48 Million $-7.63 Million -0.611x +20.24%
2022-12-31 $16.70 Million $-12.80 Million -0.766x -129.59%
2021-12-31 $35.54 Million $-11.86 Million -0.334x +61.91%
2020-12-31 $17.47 Million $-15.31 Million -0.876x -377.43%
2019-12-31 $8.02 Million $2.53 Million 0.316x +106.62%
2018-12-31 $-1.68 Million $8.02 Million -4.771x --